Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

State Council Issues New Policy for Centralized Drug Purchase of Public Hospital... The General Office of the State Council issued a new policy, Guiding Opinions for Centralized Drug Purchase of Public Hospitals. A thorough summary is prepared exclusivel... (2/28/2015) Healthcare Reform to Center on Cost Containment and Tiered Medical Service in 2015 as Pharma Industry Gears Up for e-Commerce (2/24/2015) China's Foreign Investment Revolution (2/22/2015) Forbes: Global Pharma's R&D Re-Balancing (2/17/2015) Chinese Innovation: BGI's Code for Success (2/16/2015) Control Risks: Whistleblowers Behind China's Corruption Crackdown (2/12/2015) China: Administrative Enforcement of Patents in China (2/12/2015) CFDA's First Circular in 2015 Opens A Route of Evidence collection for IP Cases Involving Pharma Products (2/11/2015) Review of Market Share Trends and Leading Suppliers in Yangtze River Vicinity Hospital Market 2011-2013 (2/10/2015) Will the Year of Wooden Sheep Bring Positive Changes to Chinese Pharma? (1/30/2015) China: Multinationals Continue to Adapt to Active Enforcement Environment (1/30/2015) China's Private Health Insurance: Navigating Uncharted Waters (1/28/2015) China Works To Regulate The Difference Between Food And Traditional Chinese Medicine (1/15/2015) What Does 2015 Have In Store For China's Healthcare Economy? (1/14/2015) Review of Chinese Pharma Deals, R&D and Regulatory Developments in 2014 (1/12/2015) China Pharmaceutical Pricing Policy: Painful Reform, High Cost, But Promising (12/31/2014) Chengdu Includes Certain Anticancers for...  (3/2/2015) ChiMed On Track to File for Two of Its N...  (3/2/2015) State Council Issues New Policy for Cent...  (2/28/2015) NDRC Approves Trial Proposals for Remote...  (2/28/2015) Upcoming Event: Pharma China Annual Foru...  (2/27/2015) (free) MicuRx Pharma Approved by the USFDA for ...  (2/27/2015) Sichuan, Shanghai to Push Forward Tiered...  (2/27/2015) Cisen Pharma, Georgia State U Agree to C...  (2/26/2015) Amarin, Eddingpharm Enter Agreement for ...  (2/26/2015) Immuron Inks Pact for China Distribution...  (2/17/2015) Financial-related Company News in Brief  (2/17/2015) Recent Executive Moves  (2/17/2015) Nicholas Hall Reports 5% Growth of OTC G...  (2/17/2015) MOHRSS: Government to Raise Subsidies to...  (2/16/2015) CFDA and USFDA China Office Hold the Fir...  (2/16/2015) (free) Pfizer to Buy Hospira for US$15 Billion GlobalData: Pharma Cos to Lose $65B by 2019 Due To Paten... Deloitte: Returns on Pharma R&D Improving as Pipelin... Improving Access to Medicine in Developing Countries 2014 The Most Active Year for Healthcare Deals in Two De... Nicholas Hall Reports 5% Growth of OTC Gastrointestinal Market ... Data Overview of the Chinese Pharmaceutical Market in 2014 Data Overview of the Chinese Retail Pharmacy Market 2006-2014 China's Mobile Healthcare to See 400% by 2017 APAC Ovarian Cancer Drug Market to Grow Modestly Before 2020 ChiMed On Track to File for Two of Its Novel Anticancers Cisen Pharma, Georgia State U Agree to Co-develop Cancer-fig... Amarin, Eddingpharm Enter Agreement for Greater China Rights... Immuron Inks Pact for China Distribution of Diarrhea Drug Financial-related Company News in Brief CFDA and USFDA China Office Hold the First Working Meeti... CFDA Finalizes New Regulation for Online Pharmacy Sales CFDA Seeks Comments on Regulation for Designated Drug Cl... CFDA Seeks Public Comments on Amendment of Chinese GCP CDE to Hold Symposium on Biosimilar Development and Eval... VellPharm Wins Lawsuit Against CFDA over Registration Proced... USTR Releases 2014 Report on China's WTO Compliance Highligh... China Makes Pledges on Pharma Business, Enforcement and IP a... Two Medical Reps Handed Jail Sentences with Probation in Sha... Fujifim to Sue Sihuan Pharma over IP Infringements Related t... EU Withdraws GMP Certification of NCPC Subsidiary USFDA Issues Warning Letter to Chinese API Producer Nova... Lonza to Manufacture Sunshine Biopharma's Novel Anticanc... Baiyunshan, Alkpharm to Join Hands for API Manufacturing... UniTao Pharma Buys Boehringer Ingelheim's API Facility i... MicuRx Pharma Approved by the USFDA for Phase II Study o... Hua Medicine Announces Positive Phase 1b Results of Its ... Chinese Scientists Develop New Anticancer Nano-Carrier Aurinia Pharma Gets Chinese and Japanese Patents for Oph... Chinese Researchers Launch Clinical Trial of Stem Cell T... Chengdu Includes Certain Anticancers for BMI Reimburseme... State Council Issues New Policy for Centralized Drug Pur... NDRC Approves Trial Proposals for Remote Medical Service... Sichuan, Shanghai to Push Forward Tiered Medical Service... MOHRSS: Government to Raise Subsidies to Urban Resident ... Recent Executive Moves Former Shanghai Health Official Handed 19-Year Jail Senten... Recent Executive Moves (Updated) Executive Moves New CFDA Minister Appointed Upcoming Event: Pharma China Annual Forum 2015 on March ... Upcoming Event: Global Vaccine and Antibody China Summit... Upcoming Event: Pharma China Annual Forum 2015 on March ... Upcoming Event: ChinaBio Partnering Forum 2015 Upcoming Event: Pharma China Annual Forum 2015 on March ... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...   WiCON Publishes China Pharmace...   WiCON officially publishes Chi...   Pharma China adds one more dis...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links